November 22, 2018
Issue 28 of Multiple Myeloma Research Review. Highlights include:  Elotuzumab monotherapy for smouldering MM Thereapetuc vulnerability of MM to Pri-17-92 inhibition Identification of novel mutational drivers reveals oncogene dependencies in MM Patient reported health-related Q0L from TOURMALINE-MM1 Download here
Continue Reading
The Center for International Blood and Marrow Transplant Research, through an alliance with Novartis, aims to track the long-term outcomes of patients treated with chimeric antigen receptor T-cell therapies. The center will collect data from children and adults treated with tisagenlecleucel (Kymriah, Novartis) who agree to participate in the center’s cellular therapy registry. “We are...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand